MDLN
Medline Inc.
$40.30
-2.71 (-6.30%)
At close · Jul 8
Market Cap
$52.94B
Shares
1,313,688,164
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$40.30
Open$42.94
Day$40.19–42.94
52W$32.82–50.88
Avg vol 30d11.3M
Short int27.6M · 2.1% float · 2.3d
Short vol50%
Last earningsAug 5, 2026
DataDec 2025–Jul 2026
Filing10-Q · May 6
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Bearish
Fundamentals
Excellent
Quant / Vol
High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+5%
above
RSI (14)
56
neutral
MACD trend
Positive
52-week position
41%
mid-range
Momentum
relative strength
1-month return
+19%
trailing
6-month return
−6%
trailing
YTD return
−4%
this year
Relative strength
−13%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
7 of 312 funds reported for Jun 30 · net -127.2K sh shares · +2 new
Insider flow
Distributing
Net -$3.6B over 90 days · 75% sells
Short interest
Rising
2.10% of float · ▲ +21.4% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
312 holders — 13F breadth
Squeeze score
62
elevated · 0–100
Fundamentals
Revenue growth
+11%
Y/Y
Gross margin
26%
contracting
Free cash flow
$1.3B
Balance sheet
$1.9B
net cash
Quant / Vol
risk profile
Volatility
43%
annualized · 1-yr
Max drawdown
−34%
past year
ATR
4.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 5, 2026
Scheduled
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 6, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance & track record
Latest guidance
· from the 8-K filed May 6, 2026
Organic Sales growth
· full year 2026
Non-GAAP
Initiated
8.5% – 9.5%
Adjusted EBITDA
· full year 2026
Non-GAAP
Initiated
$3.5B – $3.6B
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+5%
Bullish
RSI (14)
56
Neutral
MACD trend
Positive
Bullish
52-week position
41%
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
7 of 312 funds reported for Jun 30 · net -127.2K sh shares · +2 new
Insider flow
Distributing
Net -$3.6B over 90 days · 75% sells
Short interest
Rising
2.10% of float · ▲ +21.4% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
312 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $33
Now $40 · 41%
52-wk high $51
vs 50-day avg +5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted EPS non-GAAP | $0.33 | the first quarter 2026 | — |
| Adjusted EBITDA non-GAAP | $776M | the first quarter 2026 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 11% | Q1 2026 call | — |
| CapEx | $96M | Q1 2026 call | — |
| free cash flow | $316M | Q1 2026 call | — |
| Medline brand adjusted EBITDA margin non-GAAP | 22.1% | Q1 2026 call | — |
| Medline brand products | 190,000 | Q1 2026 call | — |
| net leverage | 3.1 | Q1 2026 call | — |
| Supply chain solutions adjusted EBITDA non-GAAP | $187M | Q1 2026 call | — |
| Supply chain solutions adjusted EBITDA margin non-GAAP | 4.8% | Q1 2026 call | — |
| Organic Sales non-GAAP | 10.5% | full year 2025 | — |
| Total new customer signings | $2.4B | full year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MDLN
this stock
Medline Inc.
|
$52.94B | -4.0% | +11.5% | — | 2.1% |
|
ISRG
Intuitive Surgical Inc
|
$147.01B | -26.7% | +20.5% | 50.4 | 2.2% |
|
BDX
Becton Dickinson & Co
|
$41.49B | +0.0% | +8.2% | 57.2 | 2.6% |
|
ALC
Alcon Inc
|
$32.46B | -15.5% | — | — | 1.8% |
|
RMD
Resmed Inc
|
$29.86B | -14.3% | +13.4% | 19.9 | 8.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MDLN | +2.2% | +19.2% | -6.0% | +2.2% | -4.1% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +2.4% | +18.4% | -13.4% | +2.4% | -13.4% |